Zirabev
NDC 0069-0342, bevacizumab-bvzr, injection, solution, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0069-0342
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761099
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0342 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BEVACIZUMAB400 mg/16mL
Pharmacologic classes
Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]; Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0069-0342-01 | 00069034201 | 1 VIAL, SINGLE-USE in 1 CARTON (0069-0342-01) / 16 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/aa27acbd-d117-4350-aeee-17bc2e2c0ca4Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0069-0342
Use it
Look up 0069-0342 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0342 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0069-0342. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.